Comment on: Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry. Reply to Rigalleau et al.

Grammes, J; Küstner, E; Dapp, A; Hummel, M; Kämmer, J-C; Kubiak, T; Schütz-Fuhrmann, I; Zimny, S; Bollow, E; Holl, R W

We thank Rigalleau and colleagues for taking the time to reflect critically and comment on our recent publication on continuous subcutaneous insulin infusion (CSII) in older people with type 1 diabetes [1]. As suggested by Rigalleau et al., we conducted an additional regression analysis adjusted for sex, age, duration of diabetes and depression. The difference in neuropathy in the group using CSII compared with the insulin injection therapy group remained significant. Older adults in the CSII group were indeed more likely to be diagnosed with neuropathy (71 ± 2.0% vs. 68 ± 1.7%; P = 0.006).